Cargando…

Cost-effectiveness of live oral attenuated human rotavirus vaccine in Tanzania

BACKGROUND: Globally, diarrhoea is the second leading cause of morbidity and mortality, responsible for the annual loss of about 10% of the total global childhood disease burden. In Tanzania, Rotavirus infection is the major cause of severe diarrhoea and diarrhoeal mortality in children under five y...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ruhago, George M, Ngalesoni, Frida N, Robberstad, Bjarne, Norheim, Ole F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4422135/ https://www.ncbi.nlm.nih.gov/pubmed/25949216 http://dx.doi.org/10.1186/s12962-015-0033-0

Ejemplares similares

Economic cost of primary prevention of cardiovascular diseases in Tanzania
por: Ngalesoni, Frida, et al.
Publicado: (2015)

Cost-effectiveness of medical primary prevention strategies to reduce absolute risk of cardiovascular disease in Tanzania: a Markov modelling study
por: Ngalesoni, Frida N., et al.
Publicado: (2016)

Cost-effectiveness analysis of population-based tobacco control strategies in the prevention of cardiovascular diseases in Tanzania
por: Ngalesoni, Frida, et al.
Publicado: (2017)

Cost-effectiveness of dihydroartemisinin-piperaquine compared with artemether-lumefantrine for treating uncomplicated malaria in children at a district hospital in Tanzania
por: Mori, Amani T, et al.
Publicado: (2014)

The Role of Evidence in the Decision-Making Process of Selecting Essential Medicines in Developing Countries: The Case of Tanzania
por: Mori, Amani Thomas, et al.
Publicado: (2014)

Addressing inequity to achieve the maternal and child health millennium development goals: looking beyond averages
por: Ruhago, George M, et al.
Publicado: (2012)

Cost-effectiveness of medical interventions to prevent cardiovascular disease in a sub-Saharan African country – the case of Tanzania
por: Robberstad, Bjarne, et al.
Publicado: (2007)

The public health sector supply chain costs in Tanzania
por: Ruhago, George M., et al.
Publicado: (2022)

Budget Impact Analysis of Using Dihydroartemisinin–Piperaquine to Treat Uncomplicated Malaria in Children in Tanzania
por: Mori, Amani Thomas, et al.
Publicado: (2015)

Cost-Efficiency Analysis of the Improved Web-Based Planning, Budgeting, and Reporting System (PlanRep) in Tanzania
por: Ruhago, George M., et al.
Publicado: (2022)

Understanding the implication of direct health facility financing on health commodities availability in Tanzania
por: Ruhago, George M., et al.
Publicado: (2023)

Equity implications of coverage and use of insecticide treated nets distributed for free or with co-payment in two districts in Tanzania: A cross-sectional comparative household survey
por: Ruhago, George M, et al.
Publicado: (2011)

Is cycle network expansion cost-effective? A health economic evaluation of cycling in Oslo
por: Lamu, Admassu N., et al.
Publicado: (2020)

Appraising Drugs Based on Cost-effectiveness and Severity of Disease in Norwegian Drug Coverage Decisions
por: Tranvåg, Eirik Joakim, et al.
Publicado: (2022)

Overview of the Development, Impacts, and Challenges of Live-Attenuated Oral Rotavirus Vaccines
por: Folorunso, Olufemi Samuel, et al.
Publicado: (2020)

Strengthening financial management systems at primary health care: Performance assessment of the Facility Financial Accounting and Reporting System (FFARS) in Tanzania
por: Ruhago, George M., et al.
Publicado: (2023)

Cost and cost-effectiveness of community based and health facility based directly observed treatment of tuberculosis in Dar es Salaam, Tanzania
por: Wandwalo, Eliud, et al.
Publicado: (2005)

Public participation: healthcare rationing in the newspaper media
por: Brendbekken, Audun, et al.
Publicado: (2022)

Further benefits by early start of HIV treatment in low income countries: Survival estimates of early versus deferred antiretroviral therapy
por: Johansson, Kjell Arne, et al.
Publicado: (2010)

Implementing standard antenatal care interventions: health system cost at primary health facilities in Tanzania
por: Chamani, Amisa Tindamanyile, et al.
Publicado: (2021)

The health system costs of post abortion care in Tanzania
por: Lince-Deroche, Naomi, et al.
Publicado: (2021)

Production of a vaccine against rotavirus disease; live attenuated strain containing the fourth rotavirus gene associated with attenuation
Publicado: (1991)

Public health impact and cost effectiveness of mass vaccination with live attenuated human rotavirus vaccine (RIX4414) in India: model based analysis
por: Rose, Johnie, et al.
Publicado: (2009)

Leveraging Beneficial Off-Target Effects of Live-Attenuated Rotavirus Vaccines
por: Benedicto-Matambo, Prisca, et al.
Publicado: (2022)

Pharmacoeconomics and its implication on priority-setting for essential medicines in Tanzania: a systematic review
por: Mori, Amani Thomas, et al.
Publicado: (2012)

Determinants of Focused Antenatal Care Utilization Among Women in Simiyu Region Tanzania
por: Ngowi, Agatha F., et al.
Publicado: (2023)

The role of gender inequities in women's access to reproductive health services: a population-level study of Simiyu Region Tanzania
por: Tesha, Jane, et al.
Publicado: (2023)

Rotavirus Burden, Genetic Diversity and Impact of Vaccine in Children under Five in Tanzania
por: Malakalinga, Joseph J., et al.
Publicado: (2019)

Estimating average inpatient and outpatient costs and childhood pneumonia and diarrhoea treatment costs in an urban health centre in Zambia
por: Chola, Lumbwe, et al.
Publicado: (2009)

In-vitro inhibitory effect of maternal breastmilk components on rotavirus vaccine replication and association with infant seroconversion to live oral rotavirus vaccine
por: Kazimbaya, Katayi Mwila, et al.
Publicado: (2020)

Effectiveness of the Oral Human Attenuated Rotavirus Vaccine: A Systematic Review and Meta-analysis—2006–2016
por: Willame, Corinne, et al.
Publicado: (2018)

Cost-effectiveness of Rotavirus vaccination in Vietnam
por: Kim, Sun-Young, et al.
Publicado: (2009)

Cost-effectiveness of rotavirus vaccination in Mozambique
por: Lourenço Guimarães, Esperança, et al.
Publicado: (2022)

Who benefits from increased service utilisation? Examining the distributional effects of payment for performance in Tanzania
por: Binyaruka, Peter, et al.
Publicado: (2018)

Genetic Diversity of Circulating Rotavirus Strains in Tanzania Prior to the Introduction of Vaccination
por: Moyo, Sabrina J., et al.
Publicado: (2014)

Does payment for performance increase performance inequalities across health providers? A case study of Tanzania
por: Binyaruka, Peter, et al.
Publicado: (2018)

Escherichia coli Nissle 1917 Enhances Efficacy of Oral Attenuated Human Rotavirus Vaccine in a Gnotobiotic Piglet Model
por: Michael, Husheem, et al.
Publicado: (2022)

Human resources for emergency obstetric care in northern Tanzania: distribution of quantity or quality?
por: Olsen, Øystein Evjen, et al.
Publicado: (2005)

Re-evaluating the cost and cost-effectiveness of rotavirus vaccination in Bangladesh, Ghana, and Malawi: A comparison of three rotavirus vaccines
por: Pecenka, Clint, et al.
Publicado: (2018)

An update of “Cost-effectiveness of rotavirus vaccination in the Netherlands: the results of a Consensus Rotavirus Vaccine model”
por: Tu, Hong Anh T, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_5o2uhfgu4viq3nph406uo3d9m7